[Gene therapy and animal model for inborn errors of metabolism].
作者信息
Yamamura K
出版信息
Tanpakushitsu Kakusan Koso. 1988 Apr;33(5):475-80.
PMID:3270852
Abstract
摘要
相似文献
1
[Gene therapy and animal model for inborn errors of metabolism].[先天性代谢缺陷的基因治疗与动物模型]
Tanpakushitsu Kakusan Koso. 1988 Apr;33(5):475-80.
2
[Heterogenous phenotypes associated with molecular abnormalities in inherited metabolic disorders].
Tanpakushitsu Kakusan Koso. 1988 Apr;33(5):429-32.
3
Red cell enzyme deficiencies: from genetic basis to gene transfer.
Semin Hematol. 1998 Apr;35(2):126-35.
4
Gene therapy for the circumvention of inborn errors of metabolism (IEM) caused by single-nucleotide-polymorphisms (SNPs).
Med Hypotheses. 2004;63(5):810-2. doi: 10.1016/j.mehy.2004.01.028.
5
Gene therapy for inborn errors of liver metabolism.
Mol Genet Metab. 2005 Sep-Oct;86(1-2):13-24. doi: 10.1016/j.ymgme.2005.07.015.
6
[Hereditary liver diseases. Recent molecular genetic aspects].[遗传性肝脏疾病。近期分子遗传学方面]
Dtsch Med Wochenschr. 1998 Apr 9;123(15):466-71. doi: 10.1055/s-2007-1023997.
7
[Sex difference in inborn errors of metabolism and epilepsy].[先天性代谢缺陷与癫痫中的性别差异]
No To Shinkei. 1983 Sep;35(9):877-85.
8
Patient selection may affect gene therapy success. Dominant negative effects observed for ornithine transcarbamylase in mouse and human hepatocytes.患者选择可能会影响基因治疗的成功率。在小鼠和人类肝细胞中观察到鸟氨酸转氨甲酰酶的显性负效应。
J Clin Invest. 1996 Feb 1;97(3):826-32. doi: 10.1172/JCI118482.
9
Animal analogues of human inherited metabolic diseases: molecular pathology and therapeutic studies.
Prog Clin Biol Res. 1982;94:27-65.
10
New frontiers in hereditary metabolic disease: an historical perspective.
Mol Genet Metab. 2006 Mar;87(3):184-9. doi: 10.1016/j.ymgme.2005.11.006. Epub 2006 Jan 5.
Zotero 插件